SANGAMO THERAP.INC.DL-,01 financial statements, including revenue, expenses, profit, and loss
The total revenue of GBY for the last quarter is 44.38 M EUR, and it's 13252.60% higher compared to the previous quarter. The net income of Q3 24 is 8.43 M EUR.